Hubei Jumpcan Pharmaceutical Co Ltd (600566) — Cash Flow Reinvestment Rate
Hubei Jumpcan Pharmaceutical Co Ltd (600566) has a Cash Flow Reinvestment Rate of 5.41x as of June 2025, reinvesting CN¥966.92 Million (capex CN¥15.27 Million plus investments CN¥-951.65 Million) from operating cash flow of CN¥178.57 Million. Explore Hubei Jumpcan Pharmaceutical Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hubei Jumpcan Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2000–2024)
Historical reinvestment intensity for Hubei Jumpcan Pharmaceutical Co Ltd across 24 annual periods. Also explore Hubei Jumpcan Pharmaceutical Co Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Hubei Jumpcan Pharmaceutical Co Ltd (2000–2024)
Year-by-year capital reinvestment analysis for Hubei Jumpcan Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Hubei Jumpcan Pharmaceutical Co Ltd (600566) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.94x | CN¥2.04 Billion | CN¥2.18 Billion | CN¥174.34 Million | ▲ +366.7% |
| 2023 | 0.20x | CN¥695.87 Million | CN¥3.46 Billion | CN¥301.64 Million | ▼ -67.6% |
| 2022 | 0.62x | CN¥1.62 Billion | CN¥2.62 Billion | CN¥243.66 Million | ▲ +62.3% |
| 2021 | 0.38x | CN¥723.21 Million | CN¥1.89 Billion | CN¥248.32 Million | ▼ -55.4% |
| 2020 | 0.86x | CN¥1.53 Billion | CN¥1.78 Billion | CN¥429.63 Million | ▲ +189.4% |
| 2019 | 0.30x | CN¥635.44 Million | CN¥2.15 Billion | CN¥546.44 Million | ▼ -51.1% |
| 2018 | 0.61x | CN¥1.03 Billion | CN¥1.71 Billion | CN¥668.06 Million | ▼ -40.5% |
| 2017 | 1.02x | CN¥1.21 Billion | CN¥1.19 Billion | CN¥746.25 Million | ▲ +106.5% |
| 2016 | 0.49x | CN¥449.49 Million | CN¥913.10 Million | CN¥323.49 Million | ▼ -41.8% |
| 2015 | 0.85x | CN¥545.98 Million | CN¥645.48 Million | CN¥395.98 Million | ▲ +72.8% |
| 2014 | 0.49x | CN¥301.51 Million | CN¥616.11 Million | CN¥301.51 Million | ▼ -48.0% |
| 2013 | 0.94x | CN¥270.10 Million | CN¥287.16 Million | CN¥270.10 Million | ▼ -43.1% |
| 2012 | 1.65x | CN¥44.67 Million | CN¥27.01 Million | CN¥44.67 Million | ▼ -98.9% |
| 2011 | 147.69x | CN¥60.74 Million | CN¥411.24K | CN¥60.74 Million | ▲ +9770.9% |
| 2010 | 1.50x | CN¥76.50 Million | CN¥51.13 Million | CN¥76.50 Million | ▲ +2.4% |
| 2009 | 1.46x | CN¥7.19 Million | CN¥4.92 Million | CN¥7.19 Million | ▲ +304.4% |
| 2008 | 0.36x | CN¥8.33 Million | CN¥23.05 Million | CN¥8.33 Million | ▲ +69.4% |
| 2007 | 0.21x | CN¥7.83 Million | CN¥36.72 Million | CN¥7.83 Million | ▼ -98.3% |
| 2006 | 12.22x | CN¥51.83 Million | CN¥4.24 Million | CN¥51.83 Million | ▲ +1194.8% |
| 2005 | 0.94x | CN¥59.80 Million | CN¥63.38 Million | CN¥59.80 Million | ▼ -94.7% |
| 2003 | 17.83x | CN¥39.99 Million | CN¥2.24 Million | CN¥39.99 Million | ▲ +235.0% |
| 2002 | 5.32x | CN¥117.09 Million | CN¥22.00 Million | CN¥117.09 Million | ▼ -55.1% |
| 2001 | 11.86x | CN¥88.07 Million | CN¥7.43 Million | CN¥88.07 Million | ▲ +1349.6% |
| 2000 | 0.82x | CN¥19.41 Million | CN¥23.73 Million | CN¥19.41 Million | — |